Oncimmune at Medica
The battle against cancer hinges on the early detection and then delivery of effective treatment. Oncimmune is working to revolutionise both the detection of cancer and its treatment by harnessing the sophisticated disease-detecting capabilities of the immune system to find cancer in its early stages. Oncimmune’s range of diagnostic tests assist clinicians to identify the presence of cancer on average four years before standard clinical diag-
nosis, whilst its technology platform and sample biobanks are helping healthcare companies to develop new cancer treatments.
Booth # 1F03-10